"The Report Global Hypercholesterolemia Drugs Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

Albany, NY -- (SBWire) -- 08/04/2016 --About Hypercholesterolemia

Hypercholesterolemia is characterized by high levels of total cholesterol and LDL-C in the blood. High cholesterol levels can cause CVDs such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL.Blood cholesterol contains individual components such as LDL-C and HDL-C. LDL carries cholesterol to the body and HDL removes cholesterol from the cells by reversing cholesterol transport to the liver.

Technavios analysts forecast the Global Hypercholesterolemia Drugs Market to decline at a CAGR of 6.78% during the period 2016-2020.

View Report At: http://www.marketresearchreports.biz/analysis/768163

Covered in this report

The report covers the present scenario and the growth prospects of the global hypercholesterolemia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generics, and off-label drugs used to treat hypercholesterolemia.

The market is divided into the following segments based on geography:

Americas
APAC
EMEA

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/768163

Technavio's report, Global Hypercholesterolemia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Aegerion Pharmaceuticals
AstraZeneca
Merck
Pfizer
Sanofi

Other prominent vendors
Alnylam Pharmaceuticals
Amarin
Amgen
AtheroNova
Aurobindo Pharma
Biocon
Biospherics
Bristol-Myers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
CymaBay Therapeutics
Daewoong Pharmaceutical
Daiichi Sankyo
Eli Lilly
Esperion Therapeutics
GlaxoSmithKline
HanAll BioPharma
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kowa Company
Laboratoires
Livzon Pharmaceutical
Lupin Pharmaceuticals
Madrigal Pharmaceuticals
Merz Pharmaceuticals
Mylan
Novartis
Regeneron Pharmaceuticals
ReGenX Biosciences
Santaris Pharma
Serometrix
Sun Pharmaceutical
Arbutus Biopharma
Teva Pharmaceuticals
Torrent Pharmaceuticals
Zydus Cadila

Market driver
Rising prevalence of chronic diseases
For a full, detailed list, view our report

Market challenge
Loss of patent exclusivity of branded therapies
For a full, detailed list, view our report

Market trend
Expected entry of cost-effective OTC versions
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Browse all latest Press Releases of Market Research Reports at: http://www.marketresearchreports.biz/pressreleases

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.

Contact
Mr. Nachiket
90 Sate Street,
Suite 700 Albany,
NY 12207 USA
Tel: 518-621-2074
Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz